u 37883a has been researched along with Reperfusion Injury in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asfar, P; Collin, S; Fremont-Orlowski, S; Ganster, F; Issa, K; Kimmoun, A; Levy, B; Mertes, PM | 1 |
| Chang, SW; Chen, YZ; Fang, SY; Hsu, CY; Huang, CC; Lam, CF; Liu, YC; Roan, JN; Tsai, YC | 1 |
| Galun, E; Matot, I; Rivo, J; Zeira, E | 1 |
3 other study(ies) available for u 37883a and Reperfusion Injury
| Article | Year |
|---|---|
Compared effects of inhibition and exogenous administration of hydrogen sulphide in ischaemia-reperfusion injury.
Topics: Acidosis, Lactic; Adamantane; Adenosine Triphosphate; Alkynes; Animals; Cytokines; Disease Models, Animal; Gasotransmitters; Glycine; Hemodynamics; Hydrogen Sulfide; KATP Channels; Male; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; Morpholines; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Norepinephrine; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats, Wistar; Reperfusion Injury; Shock, Hemorrhagic; Sulfides; Up-Regulation; Vasoconstrictor Agents | 2013 |
Cardiovascular protection of activating KATP channel during ischemia-reperfusion acidosis.
Topics: Acidosis; Adamantane; Animals; Aorta, Abdominal; Calcium; Dose-Response Relationship, Drug; Glyburide; Hemodynamics; KATP Channels; Morpholines; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tissue Culture Techniques; Vasodilation | 2012 |
Activation of A3 adenosine receptors attenuates lung injury after in vivo reperfusion.
Topics: Adamantane; Adenosine; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Animals; ATP-Binding Cassette Transporters; Cats; Dihydropyridines; Enzyme Inhibitors; Hemodynamics; Histamine; In Vitro Techniques; KATP Channels; Lung; Morpholines; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Pulmonary Artery; Reperfusion Injury | 2004 |